{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:02:20Z","timestamp":1791385340075,"version":"4.3.3"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.cbi.2024.111162","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T18:59:20Z","timestamp":1721674760000},"page":"111162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Salvianolic acid A attenuates non-alcoholic fatty liver disease by regulating the AMPK-IGFBP1 pathway"],"prefix":"10.1016","volume":"400","author":[{"given":"Ji","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aini","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5227-6445","authenticated-orcid":false,"given":"Dezhao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4164-4983","authenticated-orcid":false,"given":"Yifei","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.111162_bib1","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cbi.2024.111162_bib2","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.3390\/ijms22084156","article-title":"Role of insulin resistance in MAFLD","volume":"22","author":"Sakurai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111162_bib3","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/dc06-1539","article-title":"Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease","volume":"30","author":"Tolman","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2024.111162_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154868","article-title":"Diabetes and metabolic dysfunction-associated fatty liver disease","volume":"123","author":"Davis","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.cbi.2024.111162_bib5","first-page":"787","article-title":"Pathogenesis of type 2 diabetes mellitus","volume":"88","author":"DeFronzo","year":"2004","journal-title":"Med. Clin."},{"key":"10.1016\/j.cbi.2024.111162_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.tcb.2016.01.002","article-title":"Nuclear mechanisms of insulin resistance","volume":"26","author":"Kang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cbi.2024.111162_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/embo-reports\/kvf078","article-title":"Genetic manipulation of insulin signaling, action and secretion in mice","volume":"3","author":"Baudry","year":"2002","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cbi.2024.111162_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2024.111162_bib9","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1262-3636(07)70133-7","article-title":"Role of the liver in the control of carbohydrate and lipid homeostasis","volume":"30","author":"Postic","year":"2004","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.cbi.2024.111162_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cbi.2024.111162_bib11","doi-asserted-by":"crossref","first-page":"C147","DOI":"10.1016\/0303-7207(91)90086-8","article-title":"Insulin-like growth factor-binding protein-1: a role in glucose counterregulation?","volume":"79","author":"Lewitt","year":"1991","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cbi.2024.111162_bib12","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1111\/jgh.15627","article-title":"Insulin\u2010like growth factor binding protein 1 ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease","volume":"36","author":"Pan","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2024.111162_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.tem.2009.01.002","article-title":"IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis","volume":"20","author":"Wheatcroft","year":"2009","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.cbi.2024.111162_bib14","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/aps.2017.193","article-title":"Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cbi.2024.111162_bib15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2174\/1568026623666230106144509","article-title":"Plant-food-derived bioactives in managing hypertension: from current findings to upcoming effective pharmacotherapies","volume":"23","author":"Butnariu","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.cbi.2024.111162_bib16","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.7150\/ijbs.37467","article-title":"Salvianolic acid A & B: potential cytotoxic polyphenols in battle against cancer via targeting multiple signaling pathways","volume":"15","author":"Qin","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cbi.2024.111162_bib17","doi-asserted-by":"crossref","first-page":"C499","DOI":"10.1111\/1750-3841.12415","article-title":"Transformation of salvianolic acid B to salvianolic acid A in aqueous solution and the in vitro liver protective effect of the main products","volume":"79","author":"Kan","year":"2014","journal-title":"J. Food Sci."},{"key":"10.1016\/j.cbi.2024.111162_bib18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000430258","article-title":"Antidiabetic effect of salvianolic acid A on diabetic animal models via AMPK activation and mitochondrial regulation","volume":"36","author":"Qiang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2024.111162_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2011.03.054","article-title":"Effects of salvianolic scid A on plantar microcirculation and peripheral nerve function in diabetic rats","volume":"665","author":"Yang","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111162_bib20","doi-asserted-by":"crossref","first-page":"22288","DOI":"10.1074\/jbc.M115.712703","article-title":"Effects of the Nrf2 protein modulator salvianolic acid A alone or combined with metformin on diabetes-associated macrovascular and renal injury","volume":"291","author":"Wu","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2024.111162_bib21","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/molecules25051089","article-title":"Salvianolic acid A ameliorates early-stage atherosclerosis development by inhibiting NLRP3 inflammasome activation in zucker diabetic fatty rats","volume":"25","author":"Ma","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2024.111162_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1742-7835.2007.00020.x","article-title":"Effects of salvianolic acid A on oxidative stress and liver injury induced by carbon tetrachloride in rats","volume":"100","author":"Wu","year":"2007","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2024.111162_bib23","first-page":"1","article-title":"Salvianolic acid A suppresses CCl 4 -induced liver fibrosis through regulating the Nrf2\/HO-1, NF-\u03baB\/I\u03baB\u03b1, p38 MAPK, and JAK1\/STAT3 signaling pathways","author":"Li","year":"2022","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.cbi.2024.111162_bib24","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1034\/j.1600-0676.2001.210604.x","article-title":"Effects of salviainolic acid A (SA-A) on liver injury: SA-A action on hepatic peroxidation","volume":"21","author":"Liu","year":"2001","journal-title":"Liver"},{"key":"10.1016\/j.cbi.2024.111162_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3748\/wjg.v6.i3.402","article-title":"Protective actions of salvianolic acid A on hepatocyte injured by peroxidation in vitro","volume":"6","author":"Hu","year":"2000","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cbi.2024.111162_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.taap.2013.08.021","article-title":"Salvianolic acid A preconditioning confers protection against concanavalin A-induced liver injury through SIRT1-mediated repression of p66shc in mice","volume":"273","author":"Xu","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111162_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.560905","article-title":"Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111162_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117239","article-title":"Calenduloside E ameliorates non-alcoholic fatty liver disease via modulating a pyroptosis-dependent pathway","volume":"319","author":"Le","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cbi.2024.111162_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbalip.2013.09.004","article-title":"tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation","volume":"1841","author":"Li","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.cbi.2024.111162_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1009229","article-title":"Salvianolic acid A regulates pyroptosis of endothelial cells via directly targeting PKM2 and ameliorates diabetic atherosclerosis","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2024.111162_bib31","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jhep.2022.06.019","article-title":"Augmenter of liver regeneration: mitochondrial function and steatohepatitis","volume":"77","author":"Verma","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2024.111162_bib32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cell.2015.10.001","article-title":"Mitochondrial ROS signaling in organismal homeostasis","volume":"163","author":"Shadel","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2024.111162_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41580-018-0092-0","article-title":"Mitochondrial proteins: from biogenesis to functional networks","volume":"20","author":"Pfanner","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cbi.2024.111162_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1090338","article-title":"Ferroptosis in non-alcoholic liver disease: molecular mechanisms and therapeutic implications","volume":"10","author":"Cheng","year":"2023","journal-title":"Front. Nutr."},{"key":"10.1016\/j.cbi.2024.111162_bib35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41420-022-01011-7","article-title":"Bone morphogenetic protein 4 alleviates nonalcoholic steatohepatitis by inhibiting hepatic ferroptosis","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2024.111162_bib36","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse models of nonalcoholic steatohepatitis: toward optimization of their relevance to human nonalcoholic steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2024.111162_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/srep12931","article-title":"Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosis","volume":"5","author":"Schierwagen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2024.111162_bib38","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.apsb.2021.09.009","article-title":"Anthelmintics nitazoxanide protects against experimental hyperlipidemia and hepatic steatosis in hamsters and mice","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cbi.2024.111162_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142241","article-title":"Insulin signaling in health and disease","volume":"131","author":"Saltiel","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2024.111162_bib40","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/er.2008-0047","article-title":"Insulin receptor isoforms and insulin receptor\/insulin-like growth factor receptor hybrids in physiology and disease","volume":"30","author":"Belfiore","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cbi.2024.111162_bib41","first-page":"972","article-title":"The insulin receptor and its cellular targets","volume":"86","author":"Kido","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2024.111162_bib42","doi-asserted-by":"crossref","first-page":"A839","DOI":"10.1016\/j.jval.2016.08.544","article-title":"The role of insulin-like growth factor-1 on steatohepatitis","volume":"19","author":"Bulur","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.cbi.2024.111162_bib43","doi-asserted-by":"crossref","first-page":"E1640","DOI":"10.1210\/jc.2011-1227","article-title":"Nonalcoholic fatty liver disease is associated with low circulating levels of insulin-like growth factor-I","volume":"96","author":"Arturi","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cbi.2024.111162_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ghir.2018.01.003","article-title":"Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects","volume":"40","author":"Matsumoto","year":"2018","journal-title":"Growth Hormone IGF Res."},{"key":"10.1016\/j.cbi.2024.111162_bib45","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3390\/ijms19051308","article-title":"Insulin-like growth factor (IGF) system in liver diseases","volume":"19","author":"Adamek","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2024.111162_bib46","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s00125-008-1016-x","article-title":"Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men","volume":"51","author":"Lewitt","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2024.111162_bib47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-10-0301","article-title":"IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women","volume":"163","author":"Lewitt","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cbi.2024.111162_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diabet.2008.11.003","article-title":"Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the S\u00f6der\u00e5kra Cardiovascular Risk Factor Study","volume":"35","author":"Petersson","year":"2009","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.cbi.2024.111162_bib49","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/s12276-023-01072-3","article-title":"MicroRNA regulation of AMPK in nonalcoholic fatty liver disease","volume":"55","author":"Sun","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.cbi.2024.111162_bib50","first-page":"E730","article-title":"Treatment of nonalcoholic fatty liver disease: role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/j.cbi.2024.111162_bib51","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/15548627.2021.1895658","article-title":"The m\u00e9nage \u00e0 trois of autophagy, lipid droplets and liver disease","volume":"18","author":"Filali-Mouncef","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.cbi.2024.111162_bib52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s10020-023-00721-7","article-title":"Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK\/ACC signaling and inhibiting ferroptosis","volume":"29","author":"Guo","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.cbi.2024.111162_bib53","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.freeradbiomed.2022.10.322","article-title":"FNDC3B protects steatosis and ferroptosis via the AMPK pathway in alcoholic fatty liver disease","volume":"193","author":"You","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2024.111162_bib54","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.tcb.2023.05.003","article-title":"Regulation of ferroptosis by lipid metabolism","volume":"33","author":"Pope","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cbi.2024.111162_bib55","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cbi.2024.111162_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12944-019-1059-7","article-title":"Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK\/PPAR-\u03b1\/VLCAD pathway","volume":"18","author":"Bai","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.cbi.2024.111162_bib57","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.2337\/db21-0050","article-title":"The attenuation of diabetic nephropathy by annexin A1 via regulation of lipid metabolism through the AMPK\/PPAR\u03b1\/CPT1b pathway","volume":"70","author":"Wu","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2024.111162_bib58","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nm1557","article-title":"Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions","volume":"13","author":"Yamauchi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cbi.2024.111162_bib59","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1006\/bbrc.2001.4702","article-title":"Stimulation of IGF-binding protein-1 secretion by AMP-activated protein kinase","volume":"282","author":"Lewitt","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2024.111162_bib60","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2337\/db11-1164","article-title":"Sustained antidiabetic effects of a berberine-containing Chinese herbal medicine through regulation of hepatic gene expression","volume":"61","author":"Zhao","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2024.111162_bib61","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000456281","article-title":"Emodin increases expression of insulin-like growth factor binding protein 1 through activation of MEK\/ERK\/AMPK\u03b1 and interaction of PPAR\u03b3 and Sp1 in lung cancer","volume":"41","author":"Tang","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cbi.2024.111162_bib62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.semcdb.2020.04.011","article-title":"Hepatic lipid droplet homeostasis and fatty liver disease","volume":"108","author":"Seebacher","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.cbi.2024.111162_bib63","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","article-title":"Lipid droplets and liver disease: from basic biology to clinical implications","volume":"14","author":"Gluchowski","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cbi.2024.111162_bib64","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/ptr.6486","article-title":"Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db\/db mice","volume":"33","author":"Yang","year":"2019","journal-title":"Phyther. Res."},{"key":"10.1016\/j.cbi.2024.111162_bib65","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1089\/ars.2016.6776","article-title":"Oxidative stress as a critical factor in nonalcoholic fatty liver disease pathogenesis","volume":"26","author":"Spahis","year":"2017","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.cbi.2024.111162_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9547613","article-title":"Role of oxidative stress in pathophysiology of nonalcoholic fatty liver disease","volume":"2018","author":"Masarone","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cbi.2024.111162_bib67","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.cbi.2024.111162_bib68","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00204-021-02974-9","article-title":"Krebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis","volume":"95","author":"Gasmi","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.111162_bib69","doi-asserted-by":"crossref","first-page":"11816","DOI":"10.1096\/fj.202000678R","article-title":"Liver CPT1A gene therapy reduces diet\u2010induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD","volume":"34","author":"Weber","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.cbi.2024.111162_bib70","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s12906-016-1496-z","article-title":"The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1\u03b1 pathway","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Compl. Alternative Med."},{"key":"10.1016\/j.cbi.2024.111162_bib71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/aps.2009.9","article-title":"Osteogenic effects of D(+)\u03b2-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats","volume":"30","author":"Cui","year":"2009","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724003089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724003089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T05:38:02Z","timestamp":1723527482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724003089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":71,"alternative-id":["S0009279724003089"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111162","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvianolic acid A attenuates non-alcoholic fatty liver disease by regulating the AMPK-IGFBP1 pathway","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.111162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111162"}}